Singulair latest victim of generics onslaught
Deborah Weinstein
August 06 2012
The FDA green-lighted several generic successors to Merck's Singulair. It's one of several newly off-patent meds slated to drive generic ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.